New Milestone in Tuberculosis Research: Gates Foundation and Wellcome Fund $550M For Phase III Trial of GSK's Vaccine

https://www.biotecnika.org/2023/06/gsk-tuberculosis-vaccine-gets-550m-fund-for-phase-iii-trial/